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Background: Fasting induces specific molecular and metabolic adaptions in most organisms. In biomedical
research fasting is used in metabolic studies to synchronize nutritional states of study subjects. Because there is a
lack of standardization for this procedure, we need a deeper understanding of the dynamics and the molecular
mechanisms in fasting.
Results: We investigated the dynamic changes of liver gene expression and serum parameters of mice at several
time points during a 48 hour fasting experiment and then focused on the global gene expression changes in
epididymal white adipose tissue (WAT) as well as on pathways common to WAT, liver, and skeletal muscle. This
approach produced several intriguing insights: (i) rather than a sequential activation of biochemical pathways in
fasted liver, as current knowledge dictates, our data indicates a concerted parallel response; (ii) this first
characterization of the transcriptome signature of WAT of fasted mice reveals a remarkable activation of
components of the transcription apparatus; (iii) most importantly, our bioinformatic analyses indicate p53 as central
node in the regulation of fasting in major metabolic tissues; and (iv) forced expression of Ddit4, a fasting-regulated
p53 target gene, is sufficient to augment lipolysis in cultured adipocytes.
Conclusions: In summary, this combination of focused and global profiling approaches provides a comprehensive
molecular characterization of the processes operating during fasting in mice and suggests a role for p53, and its
downstream target Ddit4, as novel components in the transcriptional response to food deprivation.
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Fasting processes are evolutionarily highly conserved
adaptive responses to food deprivation in all organisms.
Mammals follow a day/night pattern that includes a
daily resting period during which the body is in a fasted
state and must adapt to the lack of nutrient intake by
changing the metabolic state in several organs and at the
systemic level. When deprived of dietary nutrients, the
body initially derives glucose from glycogen stores, which
are quickly depleted [1]. If fasting continues, peripheral* Correspondence: pathonomics@gmail.com; andreas.prokesch@tugraz.at
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reproduction in any medium, provided the ororgans switch from glucose to fatty acids as the primary
energy source. These fatty acids are mainly supplied from
adipose tissue stores where they are released from trigly-
ceride droplets by the process of lipolysis [2]. However,
the brain is not equipped to derive energy from fatty acids,
but uninterrupted maintenance of its function is essential
to organismal survival. Hence, the perhaps most astound-
ing metabolic change in fasting is the massive increase in
the hepatic production of ketone bodies, which the brain
can use as a secondary energy source [3]. The emergence
of biochemical pathways that produce and then utilize ke-
tone bodies is believed to be a major selective force in the
evolutionary history of Homo sapiens and this adaptive
process, along with others, enables human adults to sur-
vive for more than two months without food intake [1].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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under-developed countries, Western societies are facing a
pandemic of obesity with more than one third of the
population being obese in countries like the United States
of America [4]. In this context, fasting is still one of the
most efficient weight loss measures and therefore a
valuable therapeutic tool for the management of obesity
[5]. Indeed, caloric restriction and alternate-day fasting
have both been shown to increase longevity [6] and reduce
metabolic risk factors [7]. Further, a ketogenic state as in
fasting can also be elicited by low-carbohydrate diets
which are among the most efficient weight loss programs
[8] and are also used in clinical settings to treat forms of
epilepsy [9]. For these reasons it is imperative to add to
the current knowledge about the molecular underpinnings
and the systemic consequences of fasting.
In experimental animals, fasting is frequently used in
studies where nutritional states need to be synchronized
in order to keep biological variation (introduced by vary-
ing patterns of food intake) minimal and, thereby, to pro-
vide a steady baseline for all measured parameters. The
major problem with this approach is that there is no
standard protocol that the research community adheres to
and studies report fasting regimes in a wide range (from a
few hours to days) and with different day-time starting
points, often disregarding the intricate circadian regulation
on the organ and the systemic level [10]. Consequently, a
systematic meta-study identified fasting as one of the main
sources of variation between different transcriptomic
studies [11]. Hence, to estimate the impact on measured
experimental parameters when animals are fasted, a
deeper understanding of this process is needed. For in-
stance, whereas the fasting response of several mouse
tissues (liver, brain, gut, muscle, kidney) has been inves-
tigated at the transcriptome [12,13] and proteome [14]
level, a comprehensive view on gene regulation in white
adipose tissue of fasted mice is still missing.
In this work we investigated the dynamic and circadian
responses to a fasting stimulus by measuring serum
parameters and liver gene expression in fasted mice atTable 1 Weight changes of study animals
Absolute weight [g]
ZT Fed (n = 5) Fasted (n = 5)
2 0 h 26.7 ± 0.6 -
5 3 h 28 ± 0.74 26.2 ± 0.65
8 6 h 25.5 ± 1.73 28 ± 0.68
14 12 h 26.8 ± 0.93 24.8 ± 0.57
26 24 h 25.1 ± 0.69 22.9 ± 0.33
50 48 h 26.9 ± 0.44 22 ± 0.55***
Significant differences were determined with a 2-way ANOVA followed by a Bonfer
***p < 0.001). ZT: zeitgeber time (hours).several time points. Moreover, we measured the global
transcriptome response to fasting in white adipose tissue,
liver, and skeletal muscle utilizing microarray technology
followed by a host of bioinformatic analyses. Interesting
outcomes from the fasted adipose tissue data include a
strong enrichment of upregulated genes coding for pro-
teins that regulate transcription as well as apoptosis-
related genes. A major finding is the identification of the
p53 signaling pathway as a common mediator of the fast-
ing response in all three investigated tissues. Driven by
these results we focused on the p53-target gene Ddit4,
which was upregulated by fasting in all three tissues. Our
experiments showed that, in cultured adipocytes, Ddit4 is
inducible by p53 activation and its ectopic expression is
sufficient to augment lipolysis. Therefore we describe a
new molecular component in the fasting-response down-
stream of p53.Results and discussion
Kinetics of serum parameters and liver gene expression in
mice during a 48 hour fasting period
Despite a considerable amount of knowledge about the
mechanisms of fasting response in different organisms
(e.g. [1,12]), its exact timing, especially at time points
earlier than 12 hours, is still unclear. To assess the timely
fasting response of serum metabolites we measured blood
glucose, non-esterified fatty acids (NEFA), glycerol, and
β-hydroxybutyrate, as well as the hormones insulin and
corticosterone, at the start of the experiment and at five
time points during a 48 hour period (0, 3, 6, 12, 24 and
48 hours) both in fasted and in control (i.e. ad-libitum
fed) male C57Bl/6 J mice. The experiment was started
at the beginning of the light cycle (9 a.m.) when mice
are in their inactive phase. For these time points we
determined body weight and weight changes within
each group (Table 1) and measured the expression of
genes in pathways central to the fasting response in liver,
which is considered the main organ for maintaining
systemic energy homeostasis.Weight change to initial weight within groups [g]
Fed (n = 5) Fasted (n = 5)
−0.21 ± 0.62 -
−0.13 ± 0.14 −2.13 ± 0.2
−1.14 ± 0.11 −2.26 ± 0.19
−1.09 ± 0.15 −2.96 ± 0.14**
−0.48 ± 0.15 −3.5 ± 0.14**
−0.66 ± 0.29 −5.9 ± 0.42***
roni posttest to determine significance for each time point (in bold: **p < 0.01;
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fasting
A well-known and essential transcriptional response to
fasting is the upregulation of Pck1 and G6pc mRNAs
[15-17]. Pck1 (all gene names referring to mRNA tran-
scripts in this article are in italic and given according to
the unique NCBI gene symbol nomenclature; full names
can be found in the abbreviations list) participates in
controlling the flux into the gluconeogenesis (GNG)
pathway, while G6pc catalyzes the last step in this path-
way converting glucose-6-phosphate to glucose. Activa-
tion of liver GNG is essential in times of undernutritionFigure 1 Kinetics of selected metabolites/hormones and expression o
parameters and liver mRNA levels were measured in 10–12 weeks old faste
n = 5). Shading indicates light or dark cycle. Relative expression values from
values for time point 0 were set to 1. Significance was determined with a 2
significance for the single time points (*p < 0.05; **p < 0.01; ***p < 0.001).to provide the brain with glucose, its primary energy
source. We found that this upregulation occurs already
after 3 hours fasting and continues, at least in case of
Pck1 mRNA, throughout 48 hours of fasting (Figure 1A
top row). Further, we measured continuous upregulation
of Pcx as well as Gyk (Figure 1A top row). Pcx converts
pyruvate to oxaloacetate, which in turn serves as substrate
for Pck1. Gyk, which has already been shown to be upreg-
ulated by fasting in a Ppara-dependent manner [18], cata-
lyzes the first step in the glycerol phosphate shuttle which
utilizes glycerol released from triglyceride stores to be
converted into lipids or shunted into the GNG pathway.f liver genes during a 48 hour fasting period. (A) and (B) Serum
d and ad-libitum fed male C57Bl/6 J mice at several time points (each
qPCR measurements were normalized to 36b4 expression and the
-way ANOVA followed by a Bonferroni posttest to determine
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genic genes, serum levels of corticosterone (glucocorti-
coids are known as positive regulators of hepatic GNG by
regulating Pck1 and G6pc levels via the glucocorticoid
receptor [19,20]) rose immediately after onset of fasting,
showing >4-fold higher levels later in the fasting period
(Figure 1A bottom row). However, during the first 6 hours
of fasting, blood glucose levels are similar in fasted and
control-fed mice despite an immediate drop in serum in-
sulin in fasted mice (Figure 1A bottom row). This might
be explained by an early activation of glycogenolysis in the
major glucose storing tissues (i.e. muscle and liver [21]).
After 12 hours, glycogen stores seem to be depleted and
serum glucose levels are significantly lower in fasted mice,
suggesting that liver GNG is compensating only partly for
the lack of dietary glucose by keeping blood glucose levels
around 100 mg/dl (Figure 1A bottom row). Hence, our
data on the expression profiles of gluconeogenic genes
show an immediate upregulation of hepatic GNG 3 to
6 hours after food withdrawal, despite a delayed reduction
of serum glucose levels.
Increase of liver ketogenesis by three hours after onset of
fasting
One substrate for hepatic GNG is glycerol, which is
mainly derived from adipose tissue lipolysis where triglyc-
erides are hydrolyzed to glycerol and NEFA. As indicated
in Figure 1B, this process results in an increase in serum
glycerol and NEFA after 6 hours of fasting. Serum NEFA
levels normalize to the control-fed levels at the 24 hour
time point, presumably due to increased uptake and
utilization of free fatty acids in several tissues (mainly liver
and skeletal muscle) while glycogen stores are further de-
pleted. Apart from being a major energy source in times
of nutrient deprivation, adipose tissue-derived fatty acids
serve as substrate for ketogenesis, the synthesis of ketone
bodies (mainly β-hydroxybutyrate and acetoacetate) in the
liver. These ketone bodies can be used as secondary en-
ergy source by the brain, which cannot utilize fatty acids
directly [3]. In our data set, serum β-hydroxybutyrate
levels are increasing steadily over 48 hours of fasting com-
pared to ad libitum-fed control mice with the first signifi-
cant increase at 3 hours (Figure 1B bottom row). This
increase is concordant with the upregulation of liver
Hmgcs2 mRNA which is a key enzyme in liver ketogenesis
[22] (Figure 1B top row). Interestingly, liver ketogenesis
and serum β-hydroxybutyrate are increased hours before
blood glucose levels begin to drop (Figure 1A bottom
row). This dynamic argues for the involvement of other
sensors (for instance gut hormones or insulin and gluca-
gon signaling) detecting the absence of nutritional carbo-
hydrates and signaling to liver to upregulate ketogenesis
early in fasting. A recent report introduced an intriguing,
novel functional role for ketone bodies. By inhibitinghistone deacetylases, β-hydroxybutyrate was shown to in-
duce the expression of genes that protect against oxidative
damage in a variety of tissues [23]. In that study, a change
in histone deacetylation in kidney was shown at serum
β-hydroxybutyrate concentrations greater than 0.5 mM,
a level we measured already after 3 hours of food with-
drawal. Thus it is conceivable that this β-hydroxybutyrate-
mediated mechanism could be activated early on, to set
the stage for transcriptional regulation in response to
fasting.Early fasting-onset upregulation of Ppara target genes
Fgf21 is a recently discovered hormone shown to be a
major hub in the hepatic response to fasting by regulat-
ing fatty acid and glucose metabolism [24-26]. In our
data Fgf21 mRNA was elevated in liver of fasted animals
throughout the 48 hours, peaking at 24 hours (Figure 1B
top row). Furthermore, Fgf21 was shown to mediate its
effect partly via upregulation of Ppargc1a [27], a tran-
scriptional coactivator we found to be highly increased
by fasting in accordance with Fgf21 levels (Figure 1B
top row). Ppargc1a in turn increases expression of many
fasting response genes by binding and coactivating
transcription factors such as Ppara and glucocorticoid
receptor [15]. Along these lines, most genes shown in
Figure 1 are Ppara target genes (Pck1, G6pc, Pcx, Gyk,
Hmgcs2, Fgf21; see [18,25,28-30] and references therein)
arguing for the central role of this transcription factor
during fasting, evident from the phenotype of fasted
Ppara knock-out mice [31]. However, the modest changes
of liver Ppara mRNA levels (Figure 1B top row) are un-
likely to cause the strong alterations in Ppara targets
(compare for instance to Fgf21, a functional Ppara target
[25]). Rather the transactivation of Ppara by endogenous
ligands (fatty acids and their derivatives [32]), coactivation
by Ppargc1a, and synergistic regulation by other fasting-
regulated transcription factors (e.g. Foxa2 [33] and Creb
[34]) could lead to the magnitude of increase of its target
genes.
In summary, comparing expression of key liver fasting
genes to serum parameters shows a coherent picture
suggesting, in accordance with other recent studies
[12,13], a parallel activation of fasting-induced pathways
rather than a sequential response as historically believed
[1]. This response is activated as early as 3 to 6 hours
after food withdrawal and reaches a steady state be-
tween 12 and 24 hours. Our data further underlines that
Ppara acts as one major fasting hub, by coordinating
expression of its target genes. Hence, we provide a
detailed view of molecular response kinetics during a
48 hour fasting period in mice allowing one to extrapo-
late on the timely regulation of the fasting response in
liver and in the whole organism.
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adipose tissue, liver, and skeletal muscle in fasted mice
Next, we aimed to elucidate RNA abundance responses
to fasting in a systematic and genome-wide manner.
Most of the parameters determined in Figure 1 show the
highest difference between fasted and fed states at
24 hours initiating the experiment, suggesting that the
metabolic adaption to fasting has reached a first steady
state. For this reason we chose this time point for tran-
scriptome analyses of epididymal white adipose tissueFigure 2 Overview of microarray experiments in WAT, LIV, and SM 24
transcriptome study (WAT = white adipose tissue, LIV = liver, SM = skeletal
contains about 7000 probe sets differentially expressed≥ 1.3-fold (FDR5) be
of experiments clusters biological replicates together. Two outlier replicates
the data set. (C) Numbers of up- and downregulated (1.3x, FDR5) microarra
and SM of mice fasted for 24 hours. Additional file 1 provides detailed exp(WAT), liver (LIV), and skeletal muscle (SM) of fasted
and control mice (Figure 2A). Tissue-derived mRNA
from five fasted and five control mice were hybridized to
Affymetrix GeneChip arrays (Mouse Gene 1.1 ST). Two
hybridizations (fed liver #4 and fasted skeletal muscle
#1) were outliers as determined by principal component
analysis and therefore excluded from further analysis.
Hierarchical clustering of the remaining microarray data
sets showed that experiments strongly cluster by tissue
type (Figure 2B). The heatmap contains about 7000hours after onset of fasting. (A) Experimental design of the
muscle, PCA = principal component analysis). (B) The heatmap
tween fasted and fed in at least one condition. Hierarchical clustering
were identified by principal component analysis and removed from
y probe sets and RefSeq-annotated genes (in parentheses) in WAT, LIV,
ression values for these genes.
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discovery rate < 5% after multiple testing adjustment
(FDR5) in at least one condition. WAT showed the highest
number of differentially expressed probe sets between fast-
ing and fed states (1850 upregulated and 1712 downregu-
lated upon fasting, collapsing into 1491 upregulated and
1469 downregulated RefSeq-annotated genes), more than
double the number of genes regulated in liver (Figure 2C).
Additional file 1 provides the lists of probes expressed
more than 1.3-fold with an FDR5 for each of the three
tissues.
Functional annotation clustering of genes regulated in
fasted white adipose tissue
Although the transcriptome signatures of other mouse
organs, including liver and muscle, during fasting were
extensively investigated [12,13,34] and analyses of adipose
tissue transcriptomes during fasting are available (rats
[35,36], chicken [37], pigs [38], lactating goats [39]) the
current study is, to our knowledge, the first to focus on
characterization of the global gene expression response of
adipose tissue in fasted mice. Hence, we focused our initial
analysis on the WAT dataset and performed functional
annotation of the genes up - or downregulated in fasted
WAT (1.3x, FDR5) by mapping these lists onto gene
ontology (GO; [40]) and KEGG pathways [41] utilizing the
DAVID tool [42,43]. To visualize the results we employed
the functional clustering option, which combines redun-
dant entities, based on similarity of gene lists, into clusters.
Figure 3A and B respectively show the resulting clusters
from the lists of “WAT downregulated” or “WAT upregu-
lated” genes together with contributing GO domains in
parentheses. The x-axis shows the cluster group en-
richment scores representing a geometric mean (−log)
of p-values of entities in each cluster. We only show
clusters with an enrichment score larger than 3 be-
cause they contain at least one entity with a significant
p-value after multiple testing correction (<0.05). The
detailed results of the functional clustering including
terms/pathways contributing to each cluster are given
in Additional file 2.
Functional clustering of genes downregulated by
fasting in WAT (Figure 3A) yields terms related to
“mitochondria” in the cellular component (CC) GO cat-
egory, indicating suppression of mitochondrial processes
in times of energy scarcity. In the GO domain molecular
function (MF) we find “GTP-associated” terms and GO
terms related to “nucleotide binding”. GO biological pro-
cesses (BP) and KEGG pathways are found in clusters re-
lated to “steroid and sterol metabolism”, “carbohydrate
metabolism” and “biosynthesis of fatty acids and amino
acids”. Downregulation of steroid and sterol metabolism is
analyzed and discussed in more detail later. The cluster of
carbohydrate metabolism is mainly comprised of GOterms referring to catabolism of monosaccharides, like
hexose or glucose, and might reflect the shift from glucose
usage to fatty acid β-oxidation in prolonged fasting. Also
the downregulation of fatty acid and amino acid biosyn-
thesis is a plausible reaction of a fasting cell or tissue that
needs to suppress energy consuming processes which
increase anaplerotic pressure.
Genes upregulated in fasted white adipose tissue are
strongly connected to transcriptional regulation
Genes that are upregulated in fasted WAT (Figure 3B)
show the highest enrichment score for the GO MF cat-
egory related to “ion binding”, which is a rather general
and unspecific term. However, we find a cluster con-
taining 127 genes that relate to “apoptosis” and “cell
death” indicating that apoptotic pathways are activated
during fasting in WAT. Finally, we find high enrichment
in a cluster containing “nucleus”-related GO CC terms
as well as a cluster with terms referring to “regulation of
transcription” (BP and MF), both of which indicate a
strong positive influence of fasting on the transcrip-
tional program of adipose tissue. This is consistent with
WAT being the tissue with the highest number of differ-
entially regulated genes when compared to LIV and SM
(Figure 2C). To substantiate this finding we tested
whether the genes in the upregulated list are enriched
for transcriptional regulator molecules such as tran-
scription factors, cofactors and chromatin remodelers
as defined by the manually curated AnimalTFDB [44].
As a control we also tested for enrichment in the list of
genes downregulated by fasting in WAT which did not
map to “regulation of transcription”-associated GO terms
in our DAVID analysis. As shown in Additional file 3 the
WAT upregulated list contains at least double the number
of transcriptional regulators, compared to the WAT
downregulated list (e.g. 122 vs. 50 transcription factors),
and comprises 9%, 12%, and 16% of annotated mouse
transcription factors, cofactors, and chromatin remode-
lers, respectively. Additional file 3 also lists the expression
values and the annotations of regulated genes in WAT
according to the transcription factor subclasses defined in
AnimalTFDB. Based on ranking of the entire data set, the
gene-set enrichment analysis tool [45] performs a similar
analysis and yields a significant enrichment for the sub-
categories (all but HOX factors) of transcription factors
from AnimalTFDB for upregulated genes (see Figure 3C
and Additional file 3). These transcription factor families
contained 43 genes encoding zinc finger transcription
factors (including kruppel-like factors Klf4, Klf9, and
Klf15), 9 genes encoding basic leucin zippers (bZIP),
and 6 forkhead box genes that are upregulated in fasted
WAT (see Additional file 3). Among the transcription
factor-encoding genes with the highest upregulation by
fasting (14-fold) we find Irf4, which has been shown to
Figure 3 Functional annotation of genes regulated in WAT 24 hours after onset of fasting reveals activation of transcription regulatory
components. (A) and (B) DAVID functional clustering was performed with genes upregulated (A) or downregulated (B) by fasting (1.3x, FDR5).
Shown are the numbers of unique genes (inside of bars) and the enriched clusters (left of bars with contributing DAVID domains in parentheses).
The x-axis shows the cluster enrichment scores representing a geometric mean (−log) of p-values of entities in each cluster. Clusters with an
enrichment score larger than three are shown. CC = cellular components, MF = molecular functions, BP = biological processes. (C) GSEA enrichment
plots are generated by ranking all genes in the dataset by expression values, mapping transcription factor (TF) sub-categories (bZIP = basic
leucine zippers; Fox = forkhead box), cofactors, and chromatin remodelers, and calculating a cumulative enrichment score (green line).
NES = normalized enrichment score, FDR = false discovery rate.
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latter direction in a fasting-induced manner [46]. Con-
sequently, fat-specific Irf4 knock-out mice are deficient
in lipolysis and show increased adiposity [46]. Further-
more, genes encoding the transcription factors Zim1
and Peg3 are massively upregulated by fasting (21-fold
and 6-fold, respectively). Interestingly, these two genes
are adjacently located at an imprinted region on mouse
chromosome 7. The Peg3 knock-out mouse model de-
velops increased adiposity despite lower food intake.
This was attributed to developmental deficiencies that
lead to aberrant leptin signaling in the hypothalamus
[47]. However, our data suggest a direct involvement of
the Peg3/Zim1 locus in adipose tissue biology.The present study is, to our knowledge, the first to
focus on the characterization of the transcriptome re-
sponse to fasting of WAT in mice. Surprisingly, we do
not find GO mapping to the biological process “lipid
catabolism” which would be expected to be prominent
during fasting in WAT. The absence thereof could be
explained by abundant posttranscriptional regulation
of lipolysis by kinases such as protein kinase A [48]
and AMP-activated protein kinase [6] which are not
reflected at the transcript level. Instead our analyses
specifically reveal an unexpected upregulation of cell
death pathways as well as a strong enrichment of tran-
scriptional regulators among genes activated by fasting
in WAT.
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response of major metabolic tissues
By producing and exporting glucose, fatty acids, gly-
cerol, and ketone bodies WAT, LIV, and SM representFigure 4 Analyses of differentially expressed genes regulated by fast
signaling pathway. (A) Venn diagram of genes differentially regulated (1.3
genes differentially regulated in all three tissues were submitted to DAVID
shows the number of mapped genes and Benjamini-Hochberg’s correction
mapping as obtained from analysis with the commonly regulated gene list
(1: WAT, 2: SM, 3: LIV). (D) Heatmap of p53 target genes discussed in the te
between the 3 tissues. (E) and (F) Manually compiled heatmaps indicating
biosynthesis (F) pathways. Values are log2 transformed. White dots mark hithe organs mainly responsible for energy homeostasis
during a fasting period in mammals [1,21]. To reveal
common pathways we focused on 200 genes that were
regulated by fasting in all three tissues (Figure 4A,ing in all three tissues revealing an involvement of p53 and Srebp
x, FDR5) in WAT, LIV, and SM and their intersections. (B) Two hundred
functional annotation using GO terms and KEGG pathways. Count
was used for adjusting p-value for multiple testing. (C) Metacore
. The thermometers display expression levels of mapped genes
xt. Values are log2 transformed. White dots mark highest expression
expression levels of genes comprising the FA (E) and cholesterol
ghest expression between the 3 tissues.
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these genes ranked by decreasing average expression
level. Mapping the common list to GO biological pro-
cesses and KEGG using DAVID yielded one KEGG
pathway as significantly enriched after multiple testing
correction: the p53 signaling pathway (Figure 4B). Add-
itionally, an independent analysis with Metacore (GeneGo,
Inc.) focusing on networks overrepresented in the com-
mon list reveals the p53 node as the second highest scor-
ing network hub (see Additional file 4 for genes that
constitute this network; the highest scoring hub was the
ubiquitous transcription factor Sp1). The p53 transcription
factor is known to regulate a number of tumor suppressor
pathways including cellular senescence, apoptosis, and
DNA repair in response to various stressors [49,50]. About
50% of human cancers carry mutations in the p53 gene
[51]. However, evidence is now accumulating that p53
plays a prominent role in (lipid) metabolism as well
[52,53]. There is no direct evidence of a physiological
importance of p53 signaling in fasting, but some studies
report an activation of p53, and an induction of its target
genes, upon glucose deprivation in cultured cells [54,55].
In our dataset we observe a host of p53 target genes ap-
parently regulated by fasting, and a heatmap of the genes
described below is shown in Figure 4D. For instance, the
canonical p53 target Cdkn1a [49], a cell cycle regulator
better known as p21, is one of the top ranked genes in
Table 2 and is the gene with the highest fasting-induced
upregulation in liver (>10x). Another example is lipin-1
encoded by the gene Lpin1, which has recently been
described as a novel p53 target [55]. In our data Lpin1 is
upregulated in WAT, LIV, and SM by fasting. Depending
on its subcellular location lipin-1 can act to enhance fatty
acid oxidation by interacting with Ppara and Ppargc1a (in
the nucleus) [56] or, as a phosphatidate phosphatase in the
cytosol, to perform a key step in triglyceride biosynthesis
[57]. Being upregulated by fasting suggests activity of its
nuclear form to drive oxidation of fatty acids in lipid
storing tissues. Other p53 targets are the Sestrins, Sesn1
(upregulated by fasting in WAT and SM) and Sesn2
(upregulated in all 3 tissues), which have recently been
shown to be induced by fasting in liver and to protect it
from oxidative damage in a fasting/refeeding scenario
[58]. Interestingly, Sen et al. report that p53 physically
interacts with Ppargc1a [59], which we show to be
strongly upregulated in liver (Figure 1B) by qPCR as
well as in our microarray study in WAT and LIV (it is
downregulated, however, in SM). In their study Sen
et al. show that Ppargc1a can bind and thereby direct
p53 to the promoters/enhancers of pro-arrest as well as
metabolic target genes. Thus, this interaction of p53
and its coactivator Ppargc1a could lead to a tissue-
specific coordination of p53 to target genes relevant for
a proper response.Fasting-mediated downregulation of Srebp pathways is
common to major metabolic tissues
It was reported that p53 is capable of suppressing the
promoter of the gene encoding the transcription factor
sterol-regulatory element binding protein 1 (Srebp1
[60]). The Srebp family consists of three members:
Srebp1a and Srebp1c, both transcribed from the same
gene Srebf1, with Srebp-1c being the predominant
isoform to regulate lipogenesis in metabolic tissues,
such as WAT and LIV; and Srebp2, transcribed from
the Srebf2 locus and responsible for regulation of sterol
metabolism [61-63]. Consistent with these reports, a
Metacore analysis on the common list delivers “Regulation
of lipid metabolism” as top ranking pathways with the
Srebp family of transcription factors in its center
(Additional file 5). As mapped in Figure 4C, we find
Srebf1 and Srebf2 downregulated in all three tissues
(LIV Srebp2 is not mapped because it shows a significant
1.26x downregulation, not meeting our 1.3x cut-off). Con-
cordantly, established Srebp1 downstream genes, coding
for enzymes which encompass the fatty acid biosynthesis
pathway like Acss2, Acaca, Fasn, Scd1, and Scd2 [64], are
robustly down-regulated by fasting in our data (Figure 4E,
Table 2). Further, DAVID analyses for the set of commonly
regulated genes (Figure 4B) as well as for regulated liver
genes (Additional file 6) yields GO biological processes
that refer to steroid metabolism and, more specifically, to
cholesterol biosynthesis. As a pivotal regulator of choles-
terol homeostasis in cells, Srepb2 mediates its effects by
control of de novo synthesis and/or by regulation of chol-
esterol import [65]. To regulate de novo synthesis, Srebp2
(and to some extent also Srebp1) binds to promoters of
most of the enzymes in the cholesterol biosynthesis
pathway [63]. We find that transcripts for most of these
enzymes are significantly downregulated or show at
least a trend to downregulation (Figure 4F). The intern-
alization of cholesterol is regulated by Srebp-mediated
transcription of the LDL-receptor Ldlr (down in all
three tissues). Figure 4F shows a heatmap of these
Srebp2 target genes [63] and impressively demonstrates
reduction of transcripts for nearly all components of the
cholesterol biosynthesis and uptake pathway in the in-
vestigated tissues. Given the extensive and intricate net-
works that, depending on sterol or nutrient availability,
post-translationally regulate processing and activation
of membrane-bound SREBPs [66], our finding that fast-
ing broadly regulates Srebp-dependent pathways already
at the transcriptional level is rather surprising. Espe-
cially in liver, this downregulation of cholesterol biosyn-
thesis in combination with the upregulation of Hgmcs2
(Figure 1A and Figure 4F), which condenses acetoacetyl
CoA and acetyl CoA to β-hydroxy β-methylglutaryl CoA,
hints to a diversion of substrate from sterol synthesis to
ketone body synthesis.
Table 2 Fold difference in expression (fasted/fed) of transcripts regulated in WAT, LIV, and SM by fasting
UNIQID NAME WAT LIV SM UNIQID NAME WAT LIV SM
NM_029083 Ddit4 7.86 4.46 17.72 NM_133904 Acacb 2.74 −2.05 1.40
NM_007669 Cdkn1a 2.02 10.20 4.43 NM_024479 Wbscr27 1.48 −1.43 2.02
NM_007679 Cebpd 3.36 2.29 8.54 NM_016972 Slc7a8 2.03 −1.72 1.74
NM_010220 Fkbp5 3.40 5.84 4.19 NM_019873 Fkbpl −1.33 1.33 2.03
BC096647 E230001N04Rik 2.50 4.54 5.11 NM_008580 Map3k5 1.51 1.72 −1.40
NM_183187 Fam107a 3.96 3.56 3.27 NM_172648 Ifi205 1.66 −1.95 2.03
NM_008817 Peg3 6.05 2.53 2.10 NM_133748 Insig2 1.61 1.48 −1.36
NM_010559 Il6ra 2.91 2.16 4.47 NM_009104 Rrm2 −1.39 1.65 1.47
NM_016693 Map3k6 3.06 2.05 3.96 NM_009653 Alas2 1.65 −1.49 1.53
NM_027560 Arrdc2 2.74 1.65 4.48 NM_027442 Ddo 1.65 1.31 −1.33
NM_018881 Fmo2 2.51 3.18 2.75 NM_133955 Rhou 1.38 −1.50 1.70
NM_001159367 Per1 2.51 3.17 2.66 NM_010197 Fgf1 −1.33 1.47 1.37
NM_011704 Vnn1 4.48 1.78 1.96 NM_001081401 Adamts3 1.48 1.38 −1.38
NM_139306 Acer2 4.07 1.38 2.58 NR_004446 Gm7035 1.49 −1.52 1.49
NM_001077348 Plin5 2.06 2.76 3.15 NM_028595 Ms4a6c 1.41 −1.53 1.40
NM_029415 Slc10a6 2.74 1.89 3.31 NM_029620 Pcolce2 1.32 −1.40 1.33
NM_133765 Fbxo31 3.71 2.46 1.60 NM_001081317 Anubl1 1.44 −1.68 1.32
NM_201256 Eif4ebp3 3.08 3.18 1.34 NM_029494 Rab30 −1.37 3.28 −1.63
NM_001033324 Zbtb16 1.54 3.91 2.02 NM_027868 Slc41a3 −1.58 3.50 −2.49
NM_030166 Galntl2 3.09 1.63 2.67 NM_008063 Slc37a4 −1.38 1.93 −1.36
ENSMUST00000059018 1110003O08Rik 3.57 2.31 1.46 NM_029967 Adamtsl1 1.53 −1.34 −1.34
NM_013602 Mt1 1.79 3.05 2.41 NM_177471 Ccdc69 1.61 −1.34 −1.45
ENSMUST00000039517 Syde2 4.10 1.60 1.51 NM_026250 Zh2c2 −1.30 1.41 −1.37
NM_009994 Cyp1b1 3.19 1.46 2.35 NM_178111 Trp53inp2 −1.63 1.36 −1.39
NM_001013780 Slc25a34 1.83 2.19 2.98 NM_009255 Serpine2 −1.67 1.58 −1.60
NM_011817 Gadd45g 2.53 2.33 2.07 NM_001005341 Ypel2 1.39 −1.50 −1.61
NM_010706 Lgals4 2.49 2.68 1.69 NM_177351 C630028N24Rik −1.96 1.39 −1.37
NM_011366 Sorbs3 1.92 2.14 2.62 NM_026524 Mid1ip1 −1.97 −2.03 1.81
NM_011977 Slc27a1 2.27 2.99 1.35 NM_011943 Map2k6 −2.14 1.68 −2.20
NM_015763 Lpin1 1.83 2.87 1.59 NM_027950 Osgin1 −1.84 −3.45 2.46
NM_025404 Arl4d 1.58 1.84 2.84 ENSMUST00000100735 Gm10387 −1.68 1.59 −2.85
NM_153574 Fam13a 2.93 1.71 1.50 ENSMUST00000111704 Rassf8 −1.31 −1.31 −1.47
NM_001113283 BC031353 2.44 1.95 1.67 NM_011063 Pea15a −1.32 −1.45 −1.36
ENSMUST00000095691 Gm9766 1.56 1.57 2.88 BC016078 4931406C07Rik −1.33 −1.35 −1.47
NM_001077364 Tsc22d3 2.23 2.24 1.53 NM_172928 Dclk3 −1.53 −1.32 −1.30
NM_144907 Sesn2 2.50 1.72 1.64 NM_025901 Polr3k −1.40 −1.40 −1.36
BC019494 Fam134b 2.28 1.48 1.97 NM_016701 Nes −1.39 −1.39 −1.45
NM_001004468 Tacc2 1.75 1.48 2.32 NM_028651 Tmtc4 −1.47 −1.41 −1.36
NM_001081005 1500012F01Rik 1.85 1.51 2.19 NM_009448 Tuba1c −1.35 −1.66 −1.32
NM_001037709 Rusc2 1.59 1.72 2.02 NM_026102 Daam1 −1.46 −1.31 −1.57
NM_026646 Slc25a22 1.34 1.52 2.26 NM_025972 Naaa −1.52 −1.31 −1.54
NM_001033238 Cblb 1.60 1.43 2.08 NM_008150 Gpc4 −1.71 −1.32 −1.35
NM_001033352 Klhl21 1.94 1.41 1.74 NM_019440 Irgm2 −1.58 −1.39 −1.42
NM_133670 Sult1a1 1.71 1.45 1.91 NM_183180 Tspan18 −1.53 −1.36 −1.49
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Table 2 Fold difference in expression (fasted/fed) of transcripts regulated in WAT, LIV, and SM by fasting (Continued)
NM_009760 Bnip3 1.57 1.80 1.69 ENSMUST00000108947 Gm14403 −1.34 −1.60 −1.46
NR_002840 Gas5 1.53 1.36 2.17 NM_001037170 Tomm40l −1.69 −1.46 −1.31
NM_023184 Klf15 1.62 1.56 1.80 NM_011654 Tuba1b −1.34 −1.72 −1.39
NM_029166 Uhrf1bp1l 1.94 1.54 1.48 NM_001111110 Cmah −1.46 −1.49 −1.55
NM_153075 Catsper2 1.46 2.18 1.31 NM_178607 Rnf24 −1.70 −1.39 −1.45
NM_007876 Dpep1 1.71 1.78 1.44 NM_009829 Ccnd2 −1.40 −1.53 −1.66
BC150711 AI607873 1.56 1.38 1.98 NM_007486 Arhgdib −1.52 −1.69 −1.40
NM_023635 Rab27a 1.33 1.60 2.00 NM_026740 Slc46a1 −1.99 −1.32 −1.33
NM_030697 Kank3 1.70 1.61 1.60 NM_011505 Stxbp4 −1.38 −1.44 −1.82
NM_001001883 Hecw2 1.86 1.62 1.38 NM_028372 Mblac2 −1.63 −1.58 −1.44
NM_019765 Clip1 1.45 1.39 2.02 NM_001080707 Gpr155 −1.82 −1.34 −1.52
ENSMUST00000077293 Gm5785 1.38 1.67 1.79 NM_025855 Echdc1 −1.47 −1.96 −1.32
NM_146085 Apbb3 1.52 1.54 1.79 NM_026170 Ergic1 −1.93 −1.34 −1.49
NM_133865 Dclre1b 1.76 1.41 1.64 NM_009388 Tkt −1.65 −1.57 −1.55
NM_001081417 Chd7 1.31 2.01 1.46 NM_007984 Fscn1 −1.71 −1.58 −1.49
NM_022331 Herpud1 1.67 1.56 1.55 NM_133871 Ifi44 −1.66 −1.70 −1.44
NR_027965 2310061J03Rik 1.79 1.49 1.48 NM_152804 Plk2 −1.78 −1.41 −1.66
NM_020253 Nrxn2 1.87 1.53 1.33 NM_024257 Hdhd3 −1.73 −1.56 −1.59
AK051045 Snhg1 1.51 1.39 1.79 NM_008538 Marcks −1.80 −1.52 −1.57
NM_001033528 Usp36 1.37 1.42 1.89 NM_178389 Gale −1.73 −1.89 −1.31
NM_175480 Zfp612 1.65 1.56 1.41 NM_008788 Pcolce −1.64 −1.65 −1.67
NM_011728 Xpa 1.50 1.45 1.62 NM_178079 Pm20d1 −1.97 −1.44 −1.56
NM_197986 Tmem140 2.36 −1.33 3.52 NM_145545 Gbp6 −1.87 −1.68 −1.48
NM_007705 Cirbp 1.42 1.79 1.34 NM_178869 Ttll1 −1.92 −1.40 −1.75
NM_194342 Unc84b 1.55 1.39 1.58 NM_013867 Bcar3 −2.20 −1.41 −1.47
NM_144788 Hectd1 1.35 1.36 1.80 NM_007934 Enpep −2.15 −1.48 −1.47
NM_012050 Omd 1.38 1.72 1.39 NM_010357 Gsta4 −1.74 −1.71 −1.66
NM_026159 Retsat 1.35 1.59 1.53 XR_030785 Gm7172 −1.73 −1.68 −1.77
NM_027468 Cpm 1.77 1.37 1.31 NM_008209 Mr1 −2.38 −1.51 −1.33
NM_019713 Rassf1 1.52 1.33 1.55 NM_021273 Ckb −2.12 −1.64 −1.50
NM_013863 Bag3 1.42 1.55 1.42 NM_009825 Serpinh1 −2.03 −1.51 −1.76
NM_199299 Phf15 1.34 1.43 1.56 NM_010260 Gbp2 −1.87 −1.68 −1.76
NM_026929 Chac1 3.69 −1.68 2.22 XR_030619 LOC100044416 −1.90 −1.72 −1.70
NM_026448 Klhl7 1.49 1.31 1.43 NM_018734 Gbp3 −2.11 −1.37 −1.87
ENSMUST00000052189 B230317F23Rik 1.40 1.38 1.43 NM_009425 Tnfsf10 −1.79 −1.40 −2.19
NM_026493 Cspp1 1.35 1.35 1.49 NM_008695 Nid2 −2.25 −1.61 −1.55
NM_001081101 4933407H18Rik 1.47 1.36 1.33 NM_009930 Col3a1 −1.70 −1.79 −1.93
NM_001033208 Gcom1 1.50 1.34 1.32 NM_020282 Nqo2 −2.08 −1.75 −1.61
NM_198020 Trmt1 1.46 1.33 1.31 NM_010700 Ldlr −2.41 −1.60 −1.55
NM_026160 Map1lc3b 1.41 1.34 1.34 NM_007631 Ccnd1 −1.40 −2.12 −2.31
NM_138953 Ell2 1.35 1.41 1.31 ENSMUST00000071723 Akap2 −2.75 −1.44 −1.78
NM_009349 Inmt 3.33 −1.74 2.47 NM_054098 Steap4 −2.77 −1.67 −1.59
NM_183288 Sh3d20 1.31 1.37 1.35 NM_025558 Cyb5b −2.68 −1.84 −1.59
NM_019861 Ctsf 1.35 1.33 1.32 NM_025436 Sc4mol −1.81 −3.09 −1.38
NM_178873 Adck2 1.32 1.32 1.31 NM_007856 Dhcr7 −1.96 −2.81 −1.72
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Table 2 Fold difference in expression (fasted/fed) of transcripts regulated in WAT, LIV, and SM by fasting (Continued)
NM_026779 Mocos 1.37 −1.37 3.29 NM_011498 Bhlhe40 −2.09 −1.41 −3.05
NM_010442 Hmox1 1.48 −1.47 2.74 NM_011923 Angptl2 −1.80 −1.47 −3.30
NM_007521 Bach2 1.90 −1.34 2.16 NM_027249 Tlcd2 −3.24 −2.08 −1.42
NM_009346 Tead1 2.60 1.35 −1.47 NM_011579 Tgtp −2.17 −1.95 −2.95
BC049153 2610024B07Rik 2.63 1.30 −1.55 NM_010255 Gamt −5.02 −1.73 −1.53
NM_026433 Tmem100 −1.98 2.32 2.03 NM_145360 Idi1 −2.57 −4.38 −1.43
NM_018760 Slc4a4 2.22 1.49 −1.36 NM_053078 D0H4S114 −3.72 −2.12 −2.57
AY140896 LOC433762 −1.42 2.09 1.60 NM_011480 Srebf1 −3.01 −3.85 −1.56
NM_023617 Aox3 2.38 −1.53 1.40 NM_007988 Fasn −3.01 −2.69 −3.32
NM_010831 Sik1 1.83 −1.56 1.92 NM_009270 Sqle −2.49 −5.00 −1.77
NM_025638 Gdpd1 2.11 1.37 −1.40 NM_009128 Scd2 −9.70 −1.81 −2.40
Genes with >1.3x change (FDR5) in all investigated tissues.
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WAT, LIV, and SM, we hypothesize a shared mechanism
that responds to the fasting stimulus in all three tissues:
The p53 signaling pathway is activated by fasting in WAT,
LIV, and SM (perhaps via AMPK as described in [67]).
Coactivators like Ppargc1a direct p53 to promoters/
enhancers of genes targeted for transcription activation
or repression when nutrients are lacking. Upregulation
of p53 targets such as Lpin1 might contribute to the
shift of fasted tissues to fatty acid oxidation to provide
energy substrates. The observation that p53 knock-out
mice are incapable of inducing liver fatty acid oxidation
upon fasting [54] underlines this hypothesis. In addition, a
p53-mediated downregulation of Srebp1 is followed by a
repression of fatty acid biosynthesis (Figure 4C and E).
However, we note that other (parallel) pathways that are
regulated at the post-translational level, and therefore not
reflected in RNA levels, could be responsible for some of
the observed effects, such as downregulation of Srebp
transcripts. One conceivable example is the activation of
AMPK by fasting which, via subsequent deactivation of
mechanistic target of rapamycin complex 1 (mTORC1),
could be responsible for the decrease in Srebp mRNA
[62]. However, based on our analyses we propose a novel
and potentially crucial role for p53 in fasting, which even-
tually could manifest in profound transcriptional changes
in several metabolic pathways. Although functional proof
of this mechanism is necessary, several reports support
our model [52,54,55,58-60].
Validation of expression of top-ranked genes commonly
regulated by fasting in WAT, LIV, and SM
To validate the microarray data by means of qPCR we se-
lected the top 3 genes from Table 2 (highest average ex-
pression across WAT, LIV, and SM: Ddit4, Cdkn1a, and
Cebpd), none of which have previously been functionally
described in the context of fasting in mice, as well as Per1
and Fasn, known responders to food deprivation andthereby positive controls (Figure 5). Per1 is an essential
regulator in the core clock machinery of circadian rhythm
[10,68] and, in LIV and AT at the beginning of the light
phase, it was previously shown that its expression is higher
in fasting compared to control fed mice [69,70]. This dif-
ference is due to a circadian phase shift that takes place
during an extended fasting period [69]. As mentioned
above Fasn has long been known to be a downstream tar-
get gene of Srebp1 and is downregulated due to the drop
in Srebp1 levels during fasting [71,72]. The basic-leucin
zipper transcription factor Cebpd has been described in a
number of cellular contexts, such as osteogenesis and adi-
pogenesis (reviewed in [73]). Cebpd expression is known
to respond to glucocorticoids and to increased cAMP
levels, both of which could explain its upregulation upon
fasting. Cdkn1a (p21) as a major p53 target gene, is mainly
described as a cell cycle and apoptosis regulator that in-
hibits cyclin-dependent kinases [74] and has no known
role in fasting. Finally, Ddit4, a gene initially reported to
be readily induced by dexamethasone [75] as well as upon
certain cellular stresses (e.g. hypoxia [76] and exercise in
muscle [77]), shows the highest extent of upregulation in
WAT and SM in the common list (Table 2). Interestingly,
it has also been described as a p53 target gene [78], which
led us to further investigate it (see below). Hence, we con-
firmed fasting-mediated regulation of all genes selected
for qPCR validation in all three tissues (Figure 5A) and
show a strong correlation with the microarray measure-
ments for all these genes (Figure 5B, r2 = 0.91). This intro-
duces three intriguing and novel players in the response to
fasting.
Ddit4 is fasting-induced in WAT, LIV, and SM and is
inducible by p53 activation in cultured adipocytes
To investigate p53 signaling as a common fasting regula-
tor in WAT, LIV, and SM, we focused on DNA damage-
induced transcript 4 (Ddit4, aliases: Redd1, Dig2, Rtp801),
the top ranking gene in Table 2 which has been described
Figure 5 Validation of selected candidates by qPCR. (A) Five
genes differentially regulated in WAT, LIV, and SM were selected for
qPCR validation of microarray results (n = 5). All differences
indicated between fasted and control fed are significant with a
p-value < 0.05 (two-tailed, unpaired student’s t-test). (B) Scatterplot
of expression levels measured with qPCR and microarrays. Goodness
of fit (r2) is calculated with linear regression. Grey shading is according
to legend in A.
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investigated, Ddit4 mRNA is upregulated at latest by
24 hours after onset of fasting and overnight fasting is
sufficient to increase Ddit4 protein levels (Figure 6A),
which has been shown by others in gastrocnemius
muscle of rats [79]. In our data, differences in the magni-
tude of fasting-induction between the mRNA and protein
level (compare SM mRNA at the 24 h time point with
protein levels in Figure 6A) could be explained by the fact
that Ddit4 protein stability is highly regulated in different
cell systems [80-82]. However, especially in adipose tissue
Ddit4 protein seems to be stably induced when mice are
fasted. To show that Ddit4 can be directly induced by p53
in adipocytes, we treated mature C3H10T1/2 adipocytes
for 6 hours with Nutlin-3, a specific p53 activator [83].
Nutlin-3 treatment led to an increase of Ddit4 mRNA
similar to the canonical target Cdkn1a (Figure 6B). Most
importantly, Ddit4 protein was also stably induced in allreplicates (Figure 6B). In addition, the p53 targets Sesn2
and Srebf1 were regulated by Nutlin-3 in a way similar
to the in vivo fasting situation (compare their expres-
sion in Figure 6B and 4D). Hence, Ddit4 is stably in-
duced by fasting and upregulated by p53 activation in
cultured adipocytes.
Overexpression of Ddit4 is sufficient to increase lipolysis
in cultured adipocytes
In a recent report Ddit4 was shown to be involved in lipid
metabolism in adipocytes signaling via the mTORC1 path-
way [81]. Also in other studies, Ddit4 has been repeatedly
described as a negative regulator of mTORC1 in a variety
of cell types [84,85]. Interestingly, in the context of
starvation, the nutrient-sensitive mTORC1 pathway
needs to be suppressed for the proper fasting response
in liver [86] and its suppression induces lipolysis in ad-
ipocytes [87]. Hence, we examined whether upregula-
tion of Ddit4 promotes lipolysis in adipocytes by
inhibiting mTORC1 activity. For this we transiently
overexpressed Ddit4 in differentiated C3H10T1/2 adi-
pocytes (Figure 7A) and determined glycerol and FFA
in the medium as a measure of lipolysis. Indeed, we
observed a ~30% increased glycerol release and a ~40%
increased FFA release from Ddit4 overexpressing cells
compared to the empty vector control (Figure 7B),
while expression of genes in the lipolytic pathway
remained unchanged (Figure 7A). Upon β-adrenergic
stimulation (1 hour 1 μM isoproterenol) the increase
in lipolysis upon Ddit4 overexpression was still evi-
dent, although not statistically significant (Figure 7C).
However, as assayed by phosphorylation of the down-
stream target S6K1 at threonine 389, mTORC1 activity
was unchanged despite effective overexpression of Ddit4
(western blot in Figure 7A). An antibody against total
S6K1 protein served as loading control and cells treated
with rapamycin, a potent exogenous mTORC1 inhibitor,
as control for phosphorylation-specific S6K1 antibody.
Others have reported that, in SM, dexamethasone-
mediated Ddit4 increase leads to reduced mTORC1 sig-
naling [88], but, judging from our data, in adipocytes
Ddit4-mediated lipolysis seems to be independent of
mTORC1 activity. This is consistent with the observation
that the Ddit4-mTORC1 axis is functional in some cell
types but not in others [75]. Further, as knock-down of
Ddit4 was reported to decrease insulin-stimulated de-
novo lipogenesis in adipocytes [81], we wanted to rule out
that the observed increase in lipolysis upon Ddit4 overex-
pression is merely an effect of increased lipogenesis and
with that higher lipid content per se. In addition to an
unchanged phenotype as shown by mRNA expression of
adipocyte-specific genes (Figure 7A), we did not detect an
increase in the incorporation of radio-labeled glucose into
total lipids in Ddit4 overexpressing cells compared to
Figure 6 Ddit4 is induced during fasting and upregulated by p53 activation in cultured adipocytes. (A) In vivo regulation of Ddit4 in
fasted and fed mice. Relative expression values from qPCR measurements (n = 5) were normalized to 36b4 expression and the value for the first
time point was set to 1. Significance was determined with a 2-way ANOVA followed by a Bonferroni posttest to determine significance for the single
time points (*p < 0.05; **p < 0.01; ***p < 0.001). Western blots were performed with tissue samples from six month old mice fed a chow diet
(fed) or fasted overnight (fasted). Samples are from three littermates each. The following proteins served as loading controls (L.C.): β-actin for
WAT and LIV, β-tubulin for SM. (B) 10 μM Nutlin-3, a specific p53 activator, was used to treat mature C3H10T1/2 adipocytes (day 7 of differentiation) for
6 hours. qPCR mRNA measurements (n = 3) were normalized to 36b4 expression and related to control cells (treated with DMSO). A two-tailed,
unpaired student’s t-test was used to determine statistical significance (*p < 0.05; **p < 0.01; ***p < 0.001). The western blot shows data from
three independent replicates treated with Nutlin-3 (+) or DMSO (−) using β–actin as loading control.
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genesis was observed (Figure 7D), which is consistent with
a potential role of Ddit4 in regulating fasting responses in
adipocytes. Hence, our data on the p53-target Ddit4 pre-
sents a valuable example for hypothesis generation from a
large-scale data set by suggesting a new role in the fine-
tuning of the fasting-response in adipose tissue. However,
further investigation is needed to elucidate the exact
mechanism by which Ddit4 is enhancing lipolysis in adi-
pocytes, because we show that this is independent form
mTORC1 and de-novo lipogenesis.
Conclusions
In this study, we took a comprehensive view on the fast-
ing process in mice. Our combination of focused and
genome-wide approaches reveals several fasting-related
findings: (i) We provide a novel view on the immediate
and dynamic response to fasting in mice during a48 hour period. These experiments focus on the timely
regulation of liver genes relayed through the Ppara sig-
naling pathway, which manifests in coordinated changes
of serum parameters. The observed responses occur
very early (between 3 to 6 hours) after onset of fasting
and show simultaneous activation of different pathways.
(ii) To our knowledge this is the first study focusing on
the transcriptome response of white adipose tissue in
fasted mice. With our bioinformatic analyses we identify
an upregulation of apoptosis-related transcripts as well
as a strong enrichment of transcriptional control com-
ponents in the set of upregulated genes. (iii) Concen-
trating our analyses on genes regulated in the three
tissues mainly responsible for energy homeostasis during
fasting (i.e. white adipose tissue, liver, skeletal muscle), the
p53 signaling pathway appears to be a common and cen-
tral regulator of fasting, possibly partly mediating its effect
by down-regulation of the Srepb pathway. (iv) Finally, we
Figure 7 Transient overexpression of Ddit4 is sufficient to induce lipolysis in cultured adipocytes. (A)-(D) C3H10T1/2 cells were
differentiated to adipocytes for 7 days. Cells were detached and electroporated in the presence of either empty vector (pMSCV) or Ddit4
overexpression vector (pDdit4). (A) 48 hours later cells were harvested to measure mRNA (left qPCR) and protein (right western blots), and
supernatants were collected for glycerol and FFA assay. qPCR measurements (n = 3) were normalized to 36b4 expression and related to control
cells and a two-tailed, unpaired student’s t-test was used to determine statistical significance (***p < 0.001). Western blot shows 2 biological
replicates and a control treated with 100 nM rapamycin (Rapa). (B) and (C) Glycerol and FFA in cell supernatants were determined, normalized to
protein content and related to measurements from control cells to yield the relative release caused by Ddit4 overexpression in unstimulated
(B) and isoproterenol-stimulated (1 μM, 1 hour) (C) conditions. Significance was determined by a one-sample t-test (* p < 0.05). (D) Electroporated
C3H10T1/2 adipocytes were incubated overnight with medium containing 14C-labeled deoxy-glucose. Incorporated radioactivity was counted in
the lipid extract and related to controls (n = 3). A statistically significant difference was not detected by a one-sample t-test.
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gene upregulated by fasting in all three tissues, is induced
by p53 activation and sufficient to increase lipolysis in cul-
tured adipocytes. In conclusion, our transcriptome study
of three tissues combined with bioinformatic analyses and
mechanistic in vitro experiments, suggests the p53-Ddit4
axis as a novel mechanism in the fine-tuning of fasting
common to major metabolic tissues.
Methods
Mouse experiments
Experimental animal procedures were in accordance with in-
stitutional guidelines and regulations of the University of
Pennsylvania. The institutional review board of the Univer-
sity of Pennsylvania reviewed and approved all mouse experi-
ments. Male wild-type C57Bl/6 J mice (Jackson Laboratories)
were kept on regular chow (Research Diets) under standard
conditions in a 12 hours day/12 hours night cycle. At an age
of 10–12 weeks, animals were separated into two groups of
25 mice each. Food was withdrawn from the fasting group at9 a.m., while the control group had continuous ad libitum
access to their diet. Blood glucose was always determined
before sacrificing mice. Mice were sacrificed at the beginning
of the study (0 hours) and at 3, 6, 12, 24, and 48 hours after
food removal. Mice were sacrificed by CO2 inhalation and
blood was collected by intra-cardiac puncture, serum isolated
and stored at −80°C. Liver, epididymal adipose tissue, and
skeletal muscle of the thigh were dissected in that order, flash
frozen in liquid N2 and stored at −80°C until mRNA extrac-
tion. For western blot of Ddit4 tissues were dissected from
six months old, male C57Bl/6 J mice that were fasted
overnight or continuously kept on normal chow diet.
Serum parameters
Blood glucose was measured by standard glucose oxidase
glucometer test strips (One Touch Ultra, Fisher). Serum
samples were analyzed using commercially available kits
for insulin (#90080 Ultra Sensitive Mouse Insulin ELISA
Kit, Crystal Chem), NEFAs (#995-34791 and 993–35191,
Wako), glycerol (#F6428, Sigma), and β-hydroxybutyrate
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termined with a Mouse/Rat Corticosterone ELISA kit
(#55-CORMS-E01, Alpco).
Tissue isolation
Tissues were homogenized using a TissueLyser (Qiagen).
mRNA was isolated by RNeasy spin columns and the
RNeasy Lipid tissue kit (#74804, Qiagen), if needed. For
tissue western blot, tissues were homogenized (Ultra-
turax, IKA) in RIPA buffer, incubated 20 min on ice, and
centrifuged (1000 g, 10 min, 4°C). Protein phase was iso-
lated and measured with BCA kit (#23227, Pierce).
qPCR analyses
For qPCR measurements of tissue gene expression, iso-
lated total RNA was reverse transcribed using High
Capacity RNA-to-cDNA Master Mix (#4377474) and
amplified using TaqMan Universal PCR Master Mix
(#4324018) and measured using gene-specific Assays-
on-demand (all Applied Biosystems). Amplifications
were performed on an ABI Prism 7900HT machine fol-
lowing manufacturer’s protocols. PCR efficiency was
calculated from standard curves and the expression of
36b4 (time series measurements) or Gapdh (verification
of microarray measurements, Figure 5) was used for
normalization. For cell culture experiments SYBR green
qPCR was used. Total RNA was isolated with the
GeneElute Mammalian Total RNA kit (#RTN70, Sigma).
For reverse transcription Qiagen QuantiTect RT kit
(#205311) was used. cDNA was then amplified using
Sybr QPCR supermix (#11733-038, Life Technologies) on
an ABI 7000 sequence detection system. Primers used
Ddit4 (Fw: CCTGCGCGTTTGCTCATGCC; Rev: GGCC
GCACGGCTCACTGTAT); Cdkn1a (Fw: GTCTGAGCG
GCCTGAAGATTC; Rev: TGTTCCGGGCCCACCCGG
GG); Sesn2 (Fw: CGCCACTCAGAGAAGGTTCA; Rev:
ACGGGGTAGTCAGGTCATGT); Lpin1 (Fw: GTCGT
CGAGCAAGACAGATTCC; Rev: ACCAGGATCCCCA
TTCTTGG); Srebf1 (Fw: AAGCAAATCACTGAAGGAC
CTGG; Rev: AAAGACAAGGGGCTACTCTGGGAG);
Pparg2 (Fw: TGCCTATGAGCACTTCACAAGAAAT;
Rev: CGAAGTTGGTGGGCCAGAA); ATGL (Fw: GTC
CTTCACCATCCGCTTGTT; Rev: CTCTTGGCCCTCA
TCACCAG); HSL (Fw: CCATCTCACCTCCCTTGG; Rev:
TCCTTCCCGTAGGTCATAGG); Plin1 (Fw: GGTACAC
TATGTGCCGCTTCC; Rev: CTTTGCGCTCCGCCTCT);
36b4 was used for normalizaiton (Fw: CAACCCAGCT
CTGGAGAAAC; Rev: CCAACAGCATATCCCGAATC).
Expression values were calculated with an in-house tool
[89] employing the AnalyzerMiner algorithm [90].
Microarray experiments
Frozen samples of white adipose tissue, liver, and skeletal
muscle collected at the 24 hour time point were used formicroarray experiments. RNA samples were quantified
using a NanoDrop (ND-1000). RNA integrity was exam-
ined using an Agilent 2100 Bioanalyzer. RNA samples
(150 ng) with RNA integrity number >7 were used for
target amplification and labeling via the Ambion WT
Expression kit (#4411974) and Affymetrix WT Terminal
Labeling kit (#900671) following manufacturer’s protocol.
Mouse Gene 1.1 ST Array Plates (#901418, Affymetrix)
were used for microarray hybridization, wash, stain and
scan with GeneTitan hyb-wash-stain kits (#901622,
Affymetrix) and a GeneTitan instrument. GeneTitan
scanner data were collected with default parameters and
further analyzed using Partek Genomics Suite. Data
were normalized using default RMA method. A two-way
ANOVA model with an interaction term between diet (fed
or fasted) and tissue (liver, skeletal muscle and white adi-
pose tissue) was set up. Pairwise comparisons were made
between fed and fasted diet for each tissue. The resulting
p-values of significance were corrected for multiple testing
using Benjamini-Hochberg’s false discovery rate (FDR)
method. Genes within 5% FDR and changed at least by
1.3-fold in either direction were called differentially
expressed. Data was deposited in NCBI gene expression
omnibus (GEO) with the accession number GSE46495.
Functional annotations and mappings
For DAVID functional annotation, Gene IDs of differen-
tially regulated gene lists (1.3x, FDR5) were submitted to
the DAVID website [43,91]. GO_FAT terms and KEGG
pathways were considered significantly enriched if the
Benjamini-Hochberg corrected p-value was >0.05. For
functional clustering only enrichment scores (negative loga-
rithm of geometric mean of p-values of entities in each
cluster) larger than three were considered because they
contain at least one entity with a significant p-value after
multiple testing correction (<0.05). Gene-set enrichment
analysis [45] was performed with all genes from the WAT
microarrays as “expression data set” and the lists of tran-
scription factor sub-classes, cofactors, and chromatin remo-
delers from AnimalTFDB [44] as “gene sets database”.
The Venn diagram for intersection of genes differentially
expressed in all tissues was drawn using BioVenn [92].
MetaCore enrichment analysis matches gene IDs of
possible targets for the “common”, “similar” and ”unique”
sets (differentially expressed in all 3, 2 out of 3, and only 1
tissue, respectively) with gene IDs in functional ontologies
in MetaCore. The probability of a random intersection be-
tween a set of IDs the size of target list with ontology en-
tities is estimated in p-value of hypergeometric intersection.
Heatmaps for Figure 4 were generated with Genesis [93].
cDNA cloning
The Ddit4 coding sequence was PCR-amplified with cod-
ing sequence-flanking primers from mouse adipose tissue
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vector (Life Technologies) between XhoI and EcoRI re-
striction sites using standard procedures. Correct cloning
was verified by sequencing of the whole insert.Cell culture experiments
C3H10T1/2 cells were maintained in growth medium
(High-glucose Dulbecco’s modified Eagle’s medium sup-
plemented with 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin (all from Life Tech-
nologies)). Two days post-confluent cells were induced to
undergo adipogenesis by addition of 1 μM dexametha-
sone, 500 μM 3-isobutyl-1-methylxanthine, 5 μg/ml
insulin (all Sigma), and 1 μM rosiglitazone (Alexis) as
described by others [94]. From day 3 on growth
medium was only supplemented with 1 μg/ml insulin
for 2 days before switching back to normal growth
medium. For Nutlin-3 treatments day 7 adipocytes were
treated for 6 hours with 10 μM of Nutlin-3 (Sigma) or
DMSO as control, before cells were harvested for RNA
and protein analysis. For Ddit4 overexpression day 7 adi-
pocytes were detached with a trypsin (0.25%)/collagenase
(0.5 mg/ml) mix, washed and resuspended in electropor-
ation buffer R (Neon electroporation kit, #MPK1025, Life
Technologies) containing 1 μg of either empty overexpres-
sion vector (pMSCV, Life Technologies) or vector with
Ddit4 coding sequence at a concentration of 30,000 cells/μl.
Electorporation was performed in 10 μl tips with 1400 V/
30 ms pulses using a Neon transfection system (Life Tech-
nologies). Three electroporation reactions were reseeded
in one well of a 12-well plate in growth medium without
antibiotics, which was replaced by normal growth medium
on the next day for RNA, protein and glycerol measure-
ments. For FFA measurements 2% FFA-free BSA (#K31-
002, PAA) containing growth medium without FBS was
used. These media were supplemented with 100 nM rapa-
mycin or 1 μM isoproterenol for 1 hour where indicated.
After 48 hours, cells were harvested for protein and RNA
analysis, and supernatants were collected for glycerol and
FFA determination.Free fatty acid and glycerol measurements
Collected media of electroporated cells were centrifuged
at 12,000 g for 5 min and supernatants were transferred
to new tubes. FFA and glycerol contents were measured
using commercial kits (from Wako (#NEFA-HR(2)) and
Thermo Scientific (#TR22421), respectively) according
to the manufacturer’s protocol. Concentrations were de-
rived from standard values/curves and related to the
amount of protein in the same well as determined with
BCA assay (#23227, Pierce). Finally, values were related
to the empty vector control measurements to obtain
relative glycerol/FFA release in per cent.Lipogenesis assay
C3H10T1/2 adipocytes were incubated overnight with
medium (no-glucose DMEM, 10% FBS, 50 μg/mL
streptomycin, 50 units/mL penicillin) supplemented
with 0.5 g/L glucose and 0.1 μCi D[14C(U)]-glucose/ml
(ARC). Cells were washed three times with ice-cold
PBS before cellular lipids were extracted with hexane/
isopropanol (3:2, vol). The incorporated radioactivity
in the organic phase was determined by liquid scintilla-
tion counting. Counted values were corrected by pro-
tein content.
Western blot analysis
Western blot analysis was performed as we described
previously [95] with the following changes: SDS-lysis
buffer was supplemented with phosphatase inhibitor
(PhosStop, Roche) to reduce changes in phosphorylation
states, a 4-12% Bis-Tris gel (Life Technologies) was used
and 40 μg protein was loaded per lane. Antibodies used:
α-Ddit4 (# 10638-1-AP, ProteinTech Europe), α-S6K1
(#9202, Cell Signaling), α-phospho S6K1 (Thr389) (#9206,
Cell Signaling). For tissue western blot 70 μg of protein
was loaded. The following antibodies were used to detect
loading controls: β-actin (#A5316, Sigma) for WAT and
LIV and β-tubulin (#T5201, Sigma) for SM. Detection
was performed using ECL prime substrate from GE
Healthcare. Before reprobing blots were stripped with
Restore WB stripping buffer from Pierce.
Statistical analyses
To determine statistical significance in time series mea-
surements a 2-way ANOVA was used followed by a
Bonferroni posttest to determine significant differences
for the single time points. For comparative qPCR mea-
surements upon Ddit4 overexpression and Nutlin-3 treat-
ment a two-tailed, unpaired student’s t-test was used and
for FFA, glycerol and lipogenesis measurements a one-
sample t-test. A p < 0.05 was considered as statistically
significant (*p < 0.05; **p < 0.01; ***p < 0.001). qPCR
time series measurements and bar graphs are shown as
average ± SEM from independent experiments (sample
size as indicated in figure legends). Significance compu-
tation in the microarray data was performed using a
two-way ANOVA model with a Benjamini-Hochberg’s
false discovery rate (FDR) to correct for multiple testing.
In this study, transcripts with an FDR5 and >1.3-fold
difference were considered as differentially expressed be-
tween fasted and fed groups. For DAVID analyses GO
terms and KEGG pathways were considered as signifi-
cantly enriched if the Benjamini-Hochberg’s corrected p-
value was <0.05 [43]. Significant enrichment of gene lists
in transcription factors, cofactors, and chromatin remode-
lers was tested with a Chi-square test with Yate’s correc-
tion (http://graphpad.com/quickcalcs/contingency1.cfm).
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